As of 2024-12-11, the Relative Valuation of Dexcom Inc (DXCM) is 65.02 USD. This relative valuation is based on P/E multiples. With the latest stock price at 79.41 USD, the upside of Dexcom Inc based on Relative Valuation is -18.1%.
The range of the Relative Valuation is 57.35 - 79.62 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.8x - 45.7x | 41.0x |
| Forward P/E multiples | 30.1x - 35.1x | 30.7x |
| Fair Price | 57.35 - 79.62 | 65.02 |
| Upside | -27.8% - 0.3% | -18.1% |
| Date | P/E |
| 2024-12-10 | 45.56 |
| 2024-12-09 | 44.99 |
| 2024-12-06 | 44.59 |
| 2024-12-05 | 45.28 |
| 2024-12-04 | 46.48 |
| 2024-12-03 | 46.42 |
| 2024-12-02 | 45.50 |
| 2024-11-29 | 44.75 |
| 2024-11-27 | 44.81 |
| 2024-11-26 | 44.72 |
| 2024-11-25 | 44.65 |
| 2024-11-22 | 41.79 |
| 2024-11-21 | 42.72 |
| 2024-11-20 | 43.17 |
| 2024-11-19 | 42.96 |
| 2024-11-18 | 43.76 |
| 2024-11-15 | 43.54 |
| 2024-11-14 | 42.85 |
| 2024-11-13 | 41.61 |
| 2024-11-12 | 42.65 |
| 2024-11-11 | 40.34 |
| 2024-11-08 | 40.14 |
| 2024-11-07 | 39.54 |
| 2024-11-06 | 39.36 |
| 2024-11-05 | 39.59 |
| 2024-11-04 | 39.99 |
| 2024-11-01 | 40.36 |
| 2024-10-31 | 40.44 |
| 2024-10-30 | 41.19 |
| 2024-10-29 | 41.45 |
| 2024-10-28 | 41.37 |
| 2024-10-25 | 42.14 |
| 2024-10-24 | 42.94 |
| 2024-10-23 | 41.58 |
| 2024-10-22 | 41.93 |
| 2024-10-21 | 41.66 |
| 2024-10-18 | 41.53 |
| 2024-10-17 | 39.90 |
| 2024-10-16 | 40.10 |
| 2024-10-15 | 38.50 |
| 2024-10-14 | 39.69 |
| 2024-10-11 | 39.71 |
| 2024-10-10 | 39.91 |
| 2024-10-09 | 39.94 |
| 2024-10-08 | 39.83 |
| 2024-10-07 | 39.37 |
| 2024-10-04 | 39.08 |
| 2024-10-03 | 37.68 |
| 2024-10-02 | 38.50 |
| 2024-10-01 | 37.87 |